Compound information
- Natural Products
- ZC2627888
- Molecular Formula
- C21H22N4O2S
- Molecular Weight
- 394.146346944 g/mol
- Structure
-
- IUPAC Name
- 4-[4-(3-methoxyphenyl)thiazol-2-yl]-N-phenyl-piperazine-1-carboxamide
- InChI
- InChI=1S/C21H22N4O2S/c1-27-18-9-5-6-16(14-18)19-15-28-21(23-19)25-12-10-24(11-13-25)20(26)22-17-7-3-2-4-8-17/h2-9,14-15H,10-13H2,1H3,(H,22,26)
- InChI Key
- KZVGSDWQVNQWTK-UHFFFAOYSA-N
- SMILES
- COc1cccc(-c2csc(N3CCN(C(=O)Nc4ccccc4)CC3)n2)c1
- Source
- ZINC000001349907
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 4 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 57.7 Å2 | LogP | 4.357 |
LogS | -5.321 | LogD | 4.518 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.142 | Pgp substrate | 0.087 |
HIA | 0.959 | F20 % | 0.995 |
F30 % | 0.967 | Caco-2 | -4.681 |
MDCK | -4.879 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.157 | PPB | 99.784 |
VD | 0.983 | Fu | 1.782 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.996 | CYP1A2 substrate | 0.816 |
CYP2A6 substrate | 0.258 | CYP2B6 substrate | 0.677 |
CYP2C19 inhibitor | 0.978 | CYP2C19 substrate | 0.837 |
CYP2C8 substrate | 0.702 | CYP2C9 inhibitor | 0.973 |
CYP2C9 substrate | 0.779 | CYP2D6 inhibitor | 0.391 |
CYP2D6 substrate | 0.982 | CYP2E1 substrate | 0.6 |
CYP3A4 inhibitor | 0.909 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.488 | CL | 4.92 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.94 | Hepatotoxicity | 0.645 |
Mutagenicity | 0.028 | Rat Oral Acute Toxicity | 0.083 |
FDAMDD | 0.426 | Skin Sensitization | 0.983 |
Carcinogenicity | 0.854 | Eye Corrosion | 0.003 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.977 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.325 | IGC50 | 4.07 |
LC50FM | 1.357 | LC50DM | -7.128 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.82 | NR-AR-LBD | 0.232 |
NR-AhR | 0.877 | NR-Aromatase | 0.033 |
NR-ER | 0.812 | NR-ER-LBD | 0.424 |
NR-PPAR-gamma | 0.661 | SR-ARE | 0.908 |
SR-ATAD5 | 0.861 | SR-HSE | 0.14 |
SR-MMP | 0.886 | SR-p53 | 0.638 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.